Interestingly, our studies showed that MIF also plays an important role in nuclease-proficient MDA-MB-231 cancer cells that do not have POLD1 and POLE mutations, as MIF KO increases misincorporation mutations and genomic instability, delays cell cycle, and inhibits DNA synthesis and cancer growth in vitro and in mice. Here, POLD1 is linked to cancer.